Gene · 6926
TBX3: T-box transcription factor 3
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. TBX3: T-box transcription factor 3. Genes, record 6926. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/6926
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| O15119 | T-box transcription factor TBX3 | 743 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents38
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 66597 | O15119 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 1245 | O15119 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 15723 | O15119 | Espacenet |
| JP 2025517969 A | 2025-06-12 | 1245 | O15119 | Espacenet |
| JP 2025028160 A | 2025-02-28 | 15723 | O15119 | Espacenet |
| KR 1020250010750 A | 2025-01-21 | 15723 | O15119 | Espacenet |
| JP 2024109657 A | 2024-08-14 | 15562 | O15119 | Espacenet |
| US 11920164 B2 | 2024-03-05 | 129 | O15119 | Espacenet |
| US 11446398 B2 | 2022-09-20 | 87273 | O15119 | Espacenet |
| JP 2022524081 A | 2022-04-27 | 190244 | O15119 | Espacenet |
1 to 10 of 38
See all 38 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,256
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TBX3 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 30 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 14 | 2025 |
| P30DK063491 | Diabetes Research Center (DRC) | 10 | 2025 |
| R01HL086694 | From GWAS loci to blood pressure genes, variants & mechanisms - Renewal | 10 | 2025 |
| R01HL092577 | IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVAL | 10 | 2025 |
| P30CA068485 | Cancer Center Support Grant | 9 | 2025 |
| P30DK026743 | UCSF Liver Center | 7 | 2025 |
| UL1TR001881 | UCLA Clinical and Translational Science Institute | 7 | 2025 |
| ZIAHL006001 | Framingham Project/Levy | 7 | 2025 |
| P30CA125123 | Baylor College of Medicine Cancer Center - Cancer Center Support Grant | 6 | 2025 |
1 to 10 of 2,256Source NIH's project files
See all 2,256 nih grantsPapers2,253
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Metformin Drives Hepatocyte Molecular Reprogramming Through a Fibroblast Growth Factor 1-Fibroblast Growth Factor Receptor 4-T-Box Transcription Factor 3 Axis in Cholestasis. | Cell Mol Gastroenterol Hepatol | 2026 | 42822673 | PubTator, text mining | PubMed |
| Genetic loci responsible for atrioventricular block in children. | Front Cell Dev Biol | 2026 | 42798645 | PubTator, text mining | PubMed |
| Molecular Classifications and Candidate Biomarkers for Personalizing BCG Therapy in Non-Muscle-Invasive Bladder Cancer. | Biomedicines | 2026 | 42792838 | PubTator, text mining | PubMed |
| Primary breast acinic cell-like carcinoma: A report of three cases and a review of the literature. | Ann Diagn Pathol | 2026 | 42777411 | PubTator, text mining | PubMed |
| Retraction: T-box Transcription Factor Tbx3 Contributes to Human Hepatocellular Carcinoma Cell Migration and Invasion by Repressing E-Cadherin Expression. | Oncol Res | 2026 | 42769425 | PubTator, text mining | PubMed |
| Breast cancer ovarian metastases show increased activity of GPCR pathways. | bioRxiv | 2026 | 42619866 | PubTator, text mining | PubMed |
| Genomic Landscape and Perinatal Outcomes of Fetal Polydactyly: A Retrospective Cohort Study Integrating CNV-seq and Trio-ES. | Prenat Diagn | 2026 | 42390887 | PubTator, text mining | PubMed |
| Genetic Profiling of Primary Versus Metastatic Ewing Sarcoma for Therapeutic Target Identification. | Life (Basel) | 2026 | 42355429 | PubTator, text mining | PubMed |
| Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes. | J Transl Med | 2026 | 42351142 | PubTator, text mining | PubMed |
| Spatiotemporal Profiling Defines the Epithelial and Mesenchymal Transition Window in Embryonic Lung Morphogenesis. | J Dev Biol | 2026 | 42346508 | PubTator, text mining | PubMed |
1 to 10 of 2,253
See all 2,253 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/6926
GET https://conductscience.org/api/genes/v1/6926/patents?page=2